Clinical Trial Update: Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS) [Phase 3]

View source ↗

Summary

Phase 3 trial PREVENT-MINS evaluating ivabradine to prevent myocardial injury after noncardiac surgery is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Injury After Noncardiac Surgery
• Myocardial Ischemia

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Jagiellonian University | Conditions: Myocardial Injury After Noncardiac Surgery (MINS), Myocardial Ischemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING